mBio-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1241130, encodeId=0342124113015, content=偏重的研究方向：病毒 经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Aug 26 12:17:30 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225945, encodeId=b4ba122594588, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：病毒 经验分享：fuck！已经with editor一个月了，不知什么情况，为什么会这样耽误时间，真烦人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Sun Jun 12 10:46:05 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833778, encodeId=13a4833e78e3, content=审稿速度:1.0 经验分享：如果文章需要小修的话，主编建议修改后再投；如果文章需要大修的话，不能重投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Mon Sep 12 09:35:02 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219221, encodeId=c03612192215e, content=偏重的研究方向：病毒;微生物 经验分享：投稿14天，还是在编辑手里，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri May 13 00:12:21 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187724, encodeId=0060118e724c7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：病毒;细胞 经验分享：我实验室的开山之作，第一次作为通讯投给了mbio，下面是我的投稿时间： 第一次是审稿了花了2个多月，被拒但鼓励重新投 Decision Letter Sent to Author 2021-08-17 16:03 Decision Pending 2021-08-17 16:03 Editor Decision Complete 2021-08-16 10:40 Decision Pending 2021-08-16 02:09 Reviews Received 2021-08-16 02:09 Under Review 2021-07-26 18:36 With Editor- Securing Reviewers 2021-07-26 17:44 With Editor 2021-06-07 16:37 Securing Editor 2021-06-03 02:57 Manuscript Submission 2021-06-03 02:56 Manuscript Submission Started 2021-05-18 08:12 然后花了两个月时间修稿，10月份再次投过去，又审了2个多月，其中第二个审稿人不见了，又找了第三个审稿人，提了一堆问题，不过这次直接是小修；花了差不多半个月修稿，再次投上去，10天就接受了。估计这个星期会见刊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9086481326, createdName=ms7000000353198660, createdTime=Mon Jan 24 16:04:35 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850389, encodeId=591085038982, content=投稿了6天，还是with editor状态 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Mar 21 16:29:10 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193781, encodeId=76221193e81c1, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:45:41 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564886, encodeId=e51056488684, content=投了5天直接accept 惊呆都没有修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eedc2139870, createdName=1581fea663m, createdTime=Wed Dec 26 00:00:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103974, encodeId=eded11039e470, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103973, encodeId=f4f011039e3e1, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-08-26 ms7000000308199462

偏重的研究方向：病毒
经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。

29 0

[GetPortalCommentsPageByObjectIdResponse(id=1241130, encodeId=0342124113015, content=偏重的研究方向：病毒 经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Aug 26 12:17:30 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225945, encodeId=b4ba122594588, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：病毒 经验分享：fuck！已经with editor一个月了，不知什么情况，为什么会这样耽误时间，真烦人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Sun Jun 12 10:46:05 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833778, encodeId=13a4833e78e3, content=审稿速度:1.0 经验分享：如果文章需要小修的话，主编建议修改后再投；如果文章需要大修的话，不能重投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Mon Sep 12 09:35:02 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219221, encodeId=c03612192215e, content=偏重的研究方向：病毒;微生物 经验分享：投稿14天，还是在编辑手里，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri May 13 00:12:21 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187724, encodeId=0060118e724c7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：病毒;细胞 经验分享：我实验室的开山之作，第一次作为通讯投给了mbio，下面是我的投稿时间： 第一次是审稿了花了2个多月，被拒但鼓励重新投 Decision Letter Sent to Author 2021-08-17 16:03 Decision Pending 2021-08-17 16:03 Editor Decision Complete 2021-08-16 10:40 Decision Pending 2021-08-16 02:09 Reviews Received 2021-08-16 02:09 Under Review 2021-07-26 18:36 With Editor- Securing Reviewers 2021-07-26 17:44 With Editor 2021-06-07 16:37 Securing Editor 2021-06-03 02:57 Manuscript Submission 2021-06-03 02:56 Manuscript Submission Started 2021-05-18 08:12 然后花了两个月时间修稿，10月份再次投过去，又审了2个多月，其中第二个审稿人不见了，又找了第三个审稿人，提了一堆问题，不过这次直接是小修；花了差不多半个月修稿，再次投上去，10天就接受了。估计这个星期会见刊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9086481326, createdName=ms7000000353198660, createdTime=Mon Jan 24 16:04:35 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850389, encodeId=591085038982, content=投稿了6天，还是with editor状态 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Mar 21 16:29:10 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193781, encodeId=76221193e81c1, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:45:41 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564886, encodeId=e51056488684, content=投了5天直接accept 惊呆都没有修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eedc2139870, createdName=1581fea663m, createdTime=Wed Dec 26 00:00:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103974, encodeId=eded11039e470, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103973, encodeId=f4f011039e3e1, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-06-12 ms6000000949743620

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：病毒
经验分享：fuck！已经with editor一个月了，不知什么情况，为什么会这样耽误时间，真烦人！

105 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241130, encodeId=0342124113015, content=偏重的研究方向：病毒 经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Aug 26 12:17:30 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225945, encodeId=b4ba122594588, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：病毒 经验分享：fuck！已经with editor一个月了，不知什么情况，为什么会这样耽误时间，真烦人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Sun Jun 12 10:46:05 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833778, encodeId=13a4833e78e3, content=审稿速度:1.0 经验分享：如果文章需要小修的话，主编建议修改后再投；如果文章需要大修的话，不能重投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Mon Sep 12 09:35:02 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219221, encodeId=c03612192215e, content=偏重的研究方向：病毒;微生物 经验分享：投稿14天，还是在编辑手里，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri May 13 00:12:21 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187724, encodeId=0060118e724c7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：病毒;细胞 经验分享：我实验室的开山之作，第一次作为通讯投给了mbio，下面是我的投稿时间： 第一次是审稿了花了2个多月，被拒但鼓励重新投 Decision Letter Sent to Author 2021-08-17 16:03 Decision Pending 2021-08-17 16:03 Editor Decision Complete 2021-08-16 10:40 Decision Pending 2021-08-16 02:09 Reviews Received 2021-08-16 02:09 Under Review 2021-07-26 18:36 With Editor- Securing Reviewers 2021-07-26 17:44 With Editor 2021-06-07 16:37 Securing Editor 2021-06-03 02:57 Manuscript Submission 2021-06-03 02:56 Manuscript Submission Started 2021-05-18 08:12 然后花了两个月时间修稿，10月份再次投过去，又审了2个多月，其中第二个审稿人不见了，又找了第三个审稿人，提了一堆问题，不过这次直接是小修；花了差不多半个月修稿，再次投上去，10天就接受了。估计这个星期会见刊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9086481326, createdName=ms7000000353198660, createdTime=Mon Jan 24 16:04:35 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850389, encodeId=591085038982, content=投稿了6天，还是with editor状态 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Mar 21 16:29:10 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193781, encodeId=76221193e81c1, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:45:41 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564886, encodeId=e51056488684, content=投了5天直接accept 惊呆都没有修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eedc2139870, createdName=1581fea663m, createdTime=Wed Dec 26 00:00:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103974, encodeId=eded11039e470, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103973, encodeId=f4f011039e3e1, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2016-09-12 ms2466276523160074

审稿速度:1.0
经验分享：如果文章需要小修的话，主编建议修改后再投；如果文章需要大修的话，不能重投。

64 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241130, encodeId=0342124113015, content=偏重的研究方向：病毒 经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Aug 26 12:17:30 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225945, encodeId=b4ba122594588, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：病毒 经验分享：fuck！已经with editor一个月了，不知什么情况，为什么会这样耽误时间，真烦人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Sun Jun 12 10:46:05 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833778, encodeId=13a4833e78e3, content=审稿速度:1.0 经验分享：如果文章需要小修的话，主编建议修改后再投；如果文章需要大修的话，不能重投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Mon Sep 12 09:35:02 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219221, encodeId=c03612192215e, content=偏重的研究方向：病毒;微生物 经验分享：投稿14天，还是在编辑手里，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri May 13 00:12:21 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187724, encodeId=0060118e724c7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：病毒;细胞 经验分享：我实验室的开山之作，第一次作为通讯投给了mbio，下面是我的投稿时间： 第一次是审稿了花了2个多月，被拒但鼓励重新投 Decision Letter Sent to Author 2021-08-17 16:03 Decision Pending 2021-08-17 16:03 Editor Decision Complete 2021-08-16 10:40 Decision Pending 2021-08-16 02:09 Reviews Received 2021-08-16 02:09 Under Review 2021-07-26 18:36 With Editor- Securing Reviewers 2021-07-26 17:44 With Editor 2021-06-07 16:37 Securing Editor 2021-06-03 02:57 Manuscript Submission 2021-06-03 02:56 Manuscript Submission Started 2021-05-18 08:12 然后花了两个月时间修稿，10月份再次投过去，又审了2个多月，其中第二个审稿人不见了，又找了第三个审稿人，提了一堆问题，不过这次直接是小修；花了差不多半个月修稿，再次投上去，10天就接受了。估计这个星期会见刊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9086481326, createdName=ms7000000353198660, createdTime=Mon Jan 24 16:04:35 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850389, encodeId=591085038982, content=投稿了6天，还是with editor状态 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Mar 21 16:29:10 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193781, encodeId=76221193e81c1, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:45:41 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564886, encodeId=e51056488684, content=投了5天直接accept 惊呆都没有修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eedc2139870, createdName=1581fea663m, createdTime=Wed Dec 26 00:00:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103974, encodeId=eded11039e470, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103973, encodeId=f4f011039e3e1, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-05-13 ms7000000308199462

偏重的研究方向：病毒;微生物
经验分享：投稿14天，还是在编辑手里，太坑了

58 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241130, encodeId=0342124113015, content=偏重的研究方向：病毒 经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Aug 26 12:17:30 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225945, encodeId=b4ba122594588, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：病毒 经验分享：fuck！已经with editor一个月了，不知什么情况，为什么会这样耽误时间，真烦人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Sun Jun 12 10:46:05 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833778, encodeId=13a4833e78e3, content=审稿速度:1.0 经验分享：如果文章需要小修的话，主编建议修改后再投；如果文章需要大修的话，不能重投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Mon Sep 12 09:35:02 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219221, encodeId=c03612192215e, content=偏重的研究方向：病毒;微生物 经验分享：投稿14天，还是在编辑手里，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri May 13 00:12:21 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187724, encodeId=0060118e724c7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：病毒;细胞 经验分享：我实验室的开山之作，第一次作为通讯投给了mbio，下面是我的投稿时间： 第一次是审稿了花了2个多月，被拒但鼓励重新投 Decision Letter Sent to Author 2021-08-17 16:03 Decision Pending 2021-08-17 16:03 Editor Decision Complete 2021-08-16 10:40 Decision Pending 2021-08-16 02:09 Reviews Received 2021-08-16 02:09 Under Review 2021-07-26 18:36 With Editor- Securing Reviewers 2021-07-26 17:44 With Editor 2021-06-07 16:37 Securing Editor 2021-06-03 02:57 Manuscript Submission 2021-06-03 02:56 Manuscript Submission Started 2021-05-18 08:12 然后花了两个月时间修稿，10月份再次投过去，又审了2个多月，其中第二个审稿人不见了，又找了第三个审稿人，提了一堆问题，不过这次直接是小修；花了差不多半个月修稿，再次投上去，10天就接受了。估计这个星期会见刊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9086481326, createdName=ms7000000353198660, createdTime=Mon Jan 24 16:04:35 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850389, encodeId=591085038982, content=投稿了6天，还是with editor状态 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Mar 21 16:29:10 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193781, encodeId=76221193e81c1, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:45:41 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564886, encodeId=e51056488684, content=投了5天直接accept 惊呆都没有修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eedc2139870, createdName=1581fea663m, createdTime=Wed Dec 26 00:00:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103974, encodeId=eded11039e470, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103973, encodeId=f4f011039e3e1, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-01-24 ms7000000353198660

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：病毒;细胞
经验分享：我实验室的开山之作，第一次作为通讯投给了mbio，下面是我的投稿时间：
第一次是审稿了花了2个多月，被拒但鼓励重新投
Decision Letter Sent to Author 2021-08-17 16:03
Decision Pending 2021-08-17 16:03
Editor Decision Complete 2021-08-16 10:40
Decision Pending 2021-08-16 02:09
Reviews Received 2021-08-16 02:09
Under Review 2021-07-26 18:36
With Editor- Securing Reviewers 2021-07-26 17:44
With Editor 2021-06-07 16:37
Securing Editor 2021-06-03 02:57
Manuscript Submission 2021-06-03 02:56
Manuscript Submission Started 2021-05-18 08:12

然后花了两个月时间修稿，10月份再次投过去，又审了2个多月，其中第二个审稿人不见了，又找了第三个审稿人，提了一堆问题，不过这次直接是小修；花了差不多半个月修稿，再次投上去，10天就接受了。估计这个星期会见刊

72 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241130, encodeId=0342124113015, content=偏重的研究方向：病毒 经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Aug 26 12:17:30 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225945, encodeId=b4ba122594588, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：病毒 经验分享：fuck！已经with editor一个月了，不知什么情况，为什么会这样耽误时间，真烦人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Sun Jun 12 10:46:05 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833778, encodeId=13a4833e78e3, content=审稿速度:1.0 经验分享：如果文章需要小修的话，主编建议修改后再投；如果文章需要大修的话，不能重投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Mon Sep 12 09:35:02 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219221, encodeId=c03612192215e, content=偏重的研究方向：病毒;微生物 经验分享：投稿14天，还是在编辑手里，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri May 13 00:12:21 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187724, encodeId=0060118e724c7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：病毒;细胞 经验分享：我实验室的开山之作，第一次作为通讯投给了mbio，下面是我的投稿时间： 第一次是审稿了花了2个多月，被拒但鼓励重新投 Decision Letter Sent to Author 2021-08-17 16:03 Decision Pending 2021-08-17 16:03 Editor Decision Complete 2021-08-16 10:40 Decision Pending 2021-08-16 02:09 Reviews Received 2021-08-16 02:09 Under Review 2021-07-26 18:36 With Editor- Securing Reviewers 2021-07-26 17:44 With Editor 2021-06-07 16:37 Securing Editor 2021-06-03 02:57 Manuscript Submission 2021-06-03 02:56 Manuscript Submission Started 2021-05-18 08:12 然后花了两个月时间修稿，10月份再次投过去，又审了2个多月，其中第二个审稿人不见了，又找了第三个审稿人，提了一堆问题，不过这次直接是小修；花了差不多半个月修稿，再次投上去，10天就接受了。估计这个星期会见刊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9086481326, createdName=ms7000000353198660, createdTime=Mon Jan 24 16:04:35 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850389, encodeId=591085038982, content=投稿了6天，还是with editor状态 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Mar 21 16:29:10 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193781, encodeId=76221193e81c1, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:45:41 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564886, encodeId=e51056488684, content=投了5天直接accept 惊呆都没有修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eedc2139870, createdName=1581fea663m, createdTime=Wed Dec 26 00:00:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103974, encodeId=eded11039e470, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103973, encodeId=f4f011039e3e1, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2019-03-21 ms2798897682501839

投稿了6天，还是with editor状态

0 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241130, encodeId=0342124113015, content=偏重的研究方向：病毒 经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Aug 26 12:17:30 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225945, encodeId=b4ba122594588, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：病毒 经验分享：fuck！已经with editor一个月了，不知什么情况，为什么会这样耽误时间，真烦人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Sun Jun 12 10:46:05 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833778, encodeId=13a4833e78e3, content=审稿速度:1.0 经验分享：如果文章需要小修的话，主编建议修改后再投；如果文章需要大修的话，不能重投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Mon Sep 12 09:35:02 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219221, encodeId=c03612192215e, content=偏重的研究方向：病毒;微生物 经验分享：投稿14天，还是在编辑手里，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri May 13 00:12:21 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187724, encodeId=0060118e724c7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：病毒;细胞 经验分享：我实验室的开山之作，第一次作为通讯投给了mbio，下面是我的投稿时间： 第一次是审稿了花了2个多月，被拒但鼓励重新投 Decision Letter Sent to Author 2021-08-17 16:03 Decision Pending 2021-08-17 16:03 Editor Decision Complete 2021-08-16 10:40 Decision Pending 2021-08-16 02:09 Reviews Received 2021-08-16 02:09 Under Review 2021-07-26 18:36 With Editor- Securing Reviewers 2021-07-26 17:44 With Editor 2021-06-07 16:37 Securing Editor 2021-06-03 02:57 Manuscript Submission 2021-06-03 02:56 Manuscript Submission Started 2021-05-18 08:12 然后花了两个月时间修稿，10月份再次投过去，又审了2个多月，其中第二个审稿人不见了，又找了第三个审稿人，提了一堆问题，不过这次直接是小修；花了差不多半个月修稿，再次投上去，10天就接受了。估计这个星期会见刊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9086481326, createdName=ms7000000353198660, createdTime=Mon Jan 24 16:04:35 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850389, encodeId=591085038982, content=投稿了6天，还是with editor状态 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Mar 21 16:29:10 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193781, encodeId=76221193e81c1, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:45:41 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564886, encodeId=e51056488684, content=投了5天直接accept 惊呆都没有修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eedc2139870, createdName=1581fea663m, createdTime=Wed Dec 26 00:00:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103974, encodeId=eded11039e470, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103973, encodeId=f4f011039e3e1, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-02-15 梅斯助教

#期刊推荐#

91 0

[GetPortalCommentsPageByObjectIdResponse(id=1241130, encodeId=0342124113015, content=偏重的研究方向：病毒 经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Aug 26 12:17:30 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225945, encodeId=b4ba122594588, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：病毒 经验分享：fuck！已经with editor一个月了，不知什么情况，为什么会这样耽误时间，真烦人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Sun Jun 12 10:46:05 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833778, encodeId=13a4833e78e3, content=审稿速度:1.0 经验分享：如果文章需要小修的话，主编建议修改后再投；如果文章需要大修的话，不能重投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Mon Sep 12 09:35:02 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219221, encodeId=c03612192215e, content=偏重的研究方向：病毒;微生物 经验分享：投稿14天，还是在编辑手里，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri May 13 00:12:21 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187724, encodeId=0060118e724c7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：病毒;细胞 经验分享：我实验室的开山之作，第一次作为通讯投给了mbio，下面是我的投稿时间： 第一次是审稿了花了2个多月，被拒但鼓励重新投 Decision Letter Sent to Author 2021-08-17 16:03 Decision Pending 2021-08-17 16:03 Editor Decision Complete 2021-08-16 10:40 Decision Pending 2021-08-16 02:09 Reviews Received 2021-08-16 02:09 Under Review 2021-07-26 18:36 With Editor- Securing Reviewers 2021-07-26 17:44 With Editor 2021-06-07 16:37 Securing Editor 2021-06-03 02:57 Manuscript Submission 2021-06-03 02:56 Manuscript Submission Started 2021-05-18 08:12 然后花了两个月时间修稿，10月份再次投过去，又审了2个多月，其中第二个审稿人不见了，又找了第三个审稿人，提了一堆问题，不过这次直接是小修；花了差不多半个月修稿，再次投上去，10天就接受了。估计这个星期会见刊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9086481326, createdName=ms7000000353198660, createdTime=Mon Jan 24 16:04:35 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850389, encodeId=591085038982, content=投稿了6天，还是with editor状态 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Mar 21 16:29:10 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193781, encodeId=76221193e81c1, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:45:41 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564886, encodeId=e51056488684, content=投了5天直接accept 惊呆都没有修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eedc2139870, createdName=1581fea663m, createdTime=Wed Dec 26 00:00:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103974, encodeId=eded11039e470, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103973, encodeId=f4f011039e3e1, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2018-12-26 1581fea663m

投了5天直接accept 惊呆都没有修改

405 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241130, encodeId=0342124113015, content=偏重的研究方向：病毒 经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Aug 26 12:17:30 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225945, encodeId=b4ba122594588, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：病毒 经验分享：fuck！已经with editor一个月了，不知什么情况，为什么会这样耽误时间，真烦人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Sun Jun 12 10:46:05 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833778, encodeId=13a4833e78e3, content=审稿速度:1.0 经验分享：如果文章需要小修的话，主编建议修改后再投；如果文章需要大修的话，不能重投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Mon Sep 12 09:35:02 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219221, encodeId=c03612192215e, content=偏重的研究方向：病毒;微生物 经验分享：投稿14天，还是在编辑手里，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri May 13 00:12:21 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187724, encodeId=0060118e724c7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：病毒;细胞 经验分享：我实验室的开山之作，第一次作为通讯投给了mbio，下面是我的投稿时间： 第一次是审稿了花了2个多月，被拒但鼓励重新投 Decision Letter Sent to Author 2021-08-17 16:03 Decision Pending 2021-08-17 16:03 Editor Decision Complete 2021-08-16 10:40 Decision Pending 2021-08-16 02:09 Reviews Received 2021-08-16 02:09 Under Review 2021-07-26 18:36 With Editor- Securing Reviewers 2021-07-26 17:44 With Editor 2021-06-07 16:37 Securing Editor 2021-06-03 02:57 Manuscript Submission 2021-06-03 02:56 Manuscript Submission Started 2021-05-18 08:12 然后花了两个月时间修稿，10月份再次投过去，又审了2个多月，其中第二个审稿人不见了，又找了第三个审稿人，提了一堆问题，不过这次直接是小修；花了差不多半个月修稿，再次投上去，10天就接受了。估计这个星期会见刊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9086481326, createdName=ms7000000353198660, createdTime=Mon Jan 24 16:04:35 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850389, encodeId=591085038982, content=投稿了6天，还是with editor状态 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Mar 21 16:29:10 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193781, encodeId=76221193e81c1, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:45:41 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564886, encodeId=e51056488684, content=投了5天直接accept 惊呆都没有修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eedc2139870, createdName=1581fea663m, createdTime=Wed Dec 26 00:00:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103974, encodeId=eded11039e470, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103973, encodeId=f4f011039e3e1, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-29 学医的彭于晏

什么是correspondingauthor/通讯作者？

53 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241130, encodeId=0342124113015, content=偏重的研究方向：病毒 经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Aug 26 12:17:30 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225945, encodeId=b4ba122594588, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：病毒 经验分享：fuck！已经with editor一个月了，不知什么情况，为什么会这样耽误时间，真烦人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Sun Jun 12 10:46:05 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833778, encodeId=13a4833e78e3, content=审稿速度:1.0 经验分享：如果文章需要小修的话，主编建议修改后再投；如果文章需要大修的话，不能重投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Mon Sep 12 09:35:02 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219221, encodeId=c03612192215e, content=偏重的研究方向：病毒;微生物 经验分享：投稿14天，还是在编辑手里，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri May 13 00:12:21 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187724, encodeId=0060118e724c7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：病毒;细胞 经验分享：我实验室的开山之作，第一次作为通讯投给了mbio，下面是我的投稿时间： 第一次是审稿了花了2个多月，被拒但鼓励重新投 Decision Letter Sent to Author 2021-08-17 16:03 Decision Pending 2021-08-17 16:03 Editor Decision Complete 2021-08-16 10:40 Decision Pending 2021-08-16 02:09 Reviews Received 2021-08-16 02:09 Under Review 2021-07-26 18:36 With Editor- Securing Reviewers 2021-07-26 17:44 With Editor 2021-06-07 16:37 Securing Editor 2021-06-03 02:57 Manuscript Submission 2021-06-03 02:56 Manuscript Submission Started 2021-05-18 08:12 然后花了两个月时间修稿，10月份再次投过去，又审了2个多月，其中第二个审稿人不见了，又找了第三个审稿人，提了一堆问题，不过这次直接是小修；花了差不多半个月修稿，再次投上去，10天就接受了。估计这个星期会见刊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9086481326, createdName=ms7000000353198660, createdTime=Mon Jan 24 16:04:35 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850389, encodeId=591085038982, content=投稿了6天，还是with editor状态 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Mar 21 16:29:10 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193781, encodeId=76221193e81c1, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:45:41 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564886, encodeId=e51056488684, content=投了5天直接accept 惊呆都没有修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eedc2139870, createdName=1581fea663m, createdTime=Wed Dec 26 00:00:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103974, encodeId=eded11039e470, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103973, encodeId=f4f011039e3e1, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-27 乌云背后的幸福线

推荐同行评议时需要注意哪些情况？

67 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务